Whats interesting in this study is that certain patients were referred to as initial responders and these patients had more success long-term than those who did not respond as quickly
This reduction in estradiol and its insulin sensitizing effects could potentially decrease food intake and body weight in some women (67)
CVOTs on DPP-4i Data from TECOS, EXAMINE, SAVOR-TIMI53, CARMELINA, and CAROLINA showed that DPP-4i are non-inferior to the placebo or glimepiride relative to primary cardiovascular endpoints [17, 48, 49, 57, 58]
Details of clinical codes for eligibility criteria, exposure, outcomes, and confounders are in Supplementary Table S1 in the Supplementary Appendix
Lipo-C & B Vitamins appears in research contexts involving solution-format research, concentration comparison, formulation and handling studies